Evaluation of the usefulness of endoglin level as a predictor of preeclampsia in pregnant women with hypertension;Ocena przydatności ste{ogonek}żenia rozpuszczalnej endogliny jako czynnika predykcyjnego wysta{ogonek}pienia stanu przedrzucawkowego u cie{ogonek}żarnych z nadciśnieniem te{ogonek}tniczym

Ginekologia Polska

Volumn 84, Issue 10, 2013, Pages 835-840

  Gluchowska, Monika ^a   Kowalska Koprek, Urszula ^a   Karowicz Bilinska, Agata ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Arterial hypertension; Preeclampsia; Pregnancy; Soluble endoglin

Indexed keywords

BIOLOGICAL MARKER; CELL SURFACE RECEPTOR; ENG PROTEIN, HUMAN; LEUKOCYTE ANTIGEN;

ADULT; ARTICLE; BLOOD; FEMALE; HUMAN; MATERNAL HYPERTENSION; PREDICTIVE VALUE; PREECLAMPSIA; PREGNANCY; PROTEINURIA; RISK FACTOR; HYPERTENSION, PREGNANCY-INDUCED; PRE-ECLAMPSIA;

ADULT; ANTIGENS, CD; BIOLOGICAL MARKERS; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PROTEINURIA; RECEPTORS, CELL SURFACE; RISK FACTORS;

EID: 84891043651     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: 10.17772/gp/1648     Document Type: Article

References (16)

1. Cifkova R. Nadcisnienie tetnicze u kobiet w ciazy. W: Nadcisnienie tetnicze. Podrecznik European Society of Hypertension. Ed. Mancia G, Grassi G, Kjeldsen S E. Gdansk: Via Medica, 2009, 349-350.
2. Roberts J, Pearson G, Cutler J, et al. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertension. 2003, 41, 437-445.
3. Perlik M, Seremak-Mrozikiewicz A, Barlik M, et al. Warianty genetyczne sródblonkowej syntazy tlenku azotu (eNOS) w nadcisnieniu ciazowym i stanie przedrzucawkowym. Ginekol Pol. 2012, 83, 652-659.
4. Mierzynski R, Leszczynska-Gorzelak B, Haberek M, Krawczyk W. Nadcisnienie w ciazy. W: Zagrozenia zycia matek. Wybrane zagadnienia. Red. Oleszczuk J, Leszczynska-Gorzelak B. Lublin: Oddzial Lubelski Polskiego Towarzystwa Medycyny Perinatalnej, 2010, 60-73.
5. Kopczynska E, Kardymowicz H, Makarewicz R, et al. Stezenie endogliny w osoczu u chorych na raka szyjki macicy. Onkologia Info. 2009, 5, 158-162.
6. Robinson C, Johnson D. Soluble endoglin as a second-trimester marker for preeclampsia. Am J Obstet Gynecol. 2007, 197, 174.e1-174.e5.
7. Leszczynska-Gorzelak B, Poniedzialek-Czajkowska E. Rzucawka w ciazy-aktualny problem kliniczny. Perinatologia, Neonatologia i Ginekologia. 2009,2, 2, 94-101.
8. Krekora M, Zych K, Biesiada L, et al. Przydatnosc wybranych markerów biochemicznych w przewidywaniu wystapienia preeklampsji u ciezarnych. Perinatologia, Neonatologia i Ginekologia. 2011, 4, 197-201.
9. Venkatesha S, Toporsian M, Lam C, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med. 2006, 12, 642-649.
10. Levine R, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006, 355, 992-1005.
11. Rana S, Cerdeira A, Wenger J, et al. Plasma Concentrations of Soluble Endoglin versus Standard Evaluation in Patients with Suspected Preeclampsia. PLoS One. 2012, 7, e48259.
12. Stepan H, Geipel A, Schwarz F, et al. Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion. Am J Obstet Gynecol. 2008, 198, 175.e1-175.e6.
13. Staff A, Braekke K, Johnsen G, et al. Circulating concentrations of soluble endoglin(CD105) in fetal and maternal serum and in amniotic fluid in preeclampsia. Am J Obstet Gynecol. 2007, 197, 176.e1-176.e6.
14. Noori M, Donald A, Angelakopoulou A, et al. Prospective study of placental angionenic factors and maternal vascular function before and after preeclampsia and gestational hypertension. Circulation. 2011, 124, e302.
15. Powers R, Jeyabalan A, Clifton R, et al. Soluble fms-Like Tyrosine Kinase 1(sFlt1), Endoglin and Placental Growth Factor(PIGF) in Preeclampsia among High Risk Pregnancies. PLoS One. 2010, 5, e13263.
16. Vaisbuch E, Whitty J, Hassan S, et al. Circulating Angiogenic and Anti-Angiogenic Factors in Pregnant Women with Eclampsia. Am J Obstet Gynecol. 2011, 204, 152.e1-152.e9.